Sub-atomic X-ray is turning out to be progressively significant for preclinical examination. Approval of designated gadolinium tests in tissue anyway has been lumbering up to now. Therefore, a novel approach is required to evaluate the distribution of gadolinium in tissue following in vivo application. To improve the detection and quantification of Gadofluorine P deposition in scar formation and myocardial remodelling by establishing combined Magnetic Resonance Imaging and Mass Spectrometry Imaging.
Share this article